Medpace
MEDP
225 hedge funds and large institutions have $1.97B invested in Medpace in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 99 increasing their positions, 60 reducing their positions, and 33 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 60
20% more capital invested
Capital invested by funds: $1.64B → $1.97B (+$329M)
6.8% more ownership
Funds ownership: 78.04% → 84.84% (+6.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 33
3% less funds holding
Funds holding: 231 → 225 (-6)
52% less call options, than puts
Call options by funds: $4.18M | Put options by funds: $8.65M
Top Buyers
| 1 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
+$41.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$34.6M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$26.3M |
| 4 |
BlackRock
New York
|
+$23.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.3M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$15.1M |
| 2 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$12.3M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$10.5M |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$8.78M |
| 5 |
TC
Tavio Capital
New York
|
-$7.48M |
MEDP Hedge Fund Activity: Q2 2019 in Review
225 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2019, worth a combined $1.97B — up 20% from $1.64B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of MEDP and 31 opened new positions — a net loss of 2 holders — while 60 trimmed existing stakes and 99 added.
The largest buyer was Blue Harbour Group, opening a new position worth an estimated $41.8M. The largest seller was Ameriprise, cutting an estimated $15.1M.
- 225 institutional investors held Medpace (MEDP) as of Q2 2019, down from 231 in Q1 2019.
- Funds reported $1.97B of Medpace stock for Q2 2019, up 20% quarter-over-quarter.
- 31 funds opened new Medpace positions in Q2 2019 and 33 closed out, a net change of -2 holders.
- The largest Medpace buyer in Q2 2019 was Blue Harbour Group, an estimated $41.8M added.
- The largest Medpace seller in Q2 2019 was Ameriprise, an estimated $15.1M sold.
Based on aggregated 13F filings for Q2 2019.